Analgesics in Ecuador

  • March 2014
  • -
  • Euromonitor International
  • -
  • 21 pages

In 2012, dengue fever grew rapidly and led to OTC to Rx switches of analgesics. In 2013, it was even worse. Dengue fever affected over 4% more people in 2013 than in 2012. This led to an OTC to Rx switch of Ibuprofen, Diclofenac, Aspirin and Naproxen since February 2013. This was done to prevent worsening self-medication by turning dengue fever into dengue haemorrhagic fever (DHF). Furthermore, the AH1N1 virus reappeared in the middle of the year, which increased the switch of OTC to Rx status...

Euromonitor International's Analgesics in Ecuador report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2009-2013, allowing you to identify the sectors driving growth. Forecasts to 2018 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.


Table Of Contents

Analgesics in Ecuador
ANALGESICS IN ECUADOR
Euromonitor International
March 2014

LIST OF CONTENTS AND TABLES

Headlines
Trends
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Analgesics by Category: Value 2008-2013
Table 2 Sales of Analgesics by Category: % Value Growth 2008-2013
Table 3 Sales of Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2008-2013
Table 4 NBO Company Shares of Analgesics: % Value 2009-2013
Table 5 LBN Brand Shares of Analgesics: % Value 2010-2013
Table 6 Forecast Sales of Analgesics by Category: Value 2013-2018
Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2013-2018
Boehringer Ingelheim Del Ecuador Cía Ltda in Consumer Health (ecuador)
Strategic Direction
Key Facts
Summary 1 Boehringer Ingelheim del Ecuador Cía Ltda: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 2 Boehringer Ingelheim del Ecuador Cía Ltda: Competitive Position 2013
Executive Summary
Slowdown in Growth
Consumers More Interested in Their Health
Foreign Firms Lead Sales
Specialists Remain the Leaders
More Controls Mean A Less Attractive Future
Key Trends and Developments
Ongoing OTC To Rx Switches
Ecuadorians Are Becoming More Interested in Exercising
Advertising and Its Role in Self-medication
Obesity and Its Causes of Growth in Ecuador
Market Indicators
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2008-2013
Table 9 Life Expectancy at Birth 2008-2013
Market Data
Table 10 Sales of Consumer Health by Category: Value 2008-2013
Table 11 Sales of Consumer Health by Category: % Value Growth 2008-2013
Table 12 NBO Company Shares of Consumer Health: % Value 2009-2013
Table 13 LBN Brand Shares of Consumer Health: % Value 2010-2013
Table 14 Distribution of Consumer Health by Format: % Value 2008-2013
Table 15 Distribution of Consumer Health by Format and Category: % Value 2013
Table 16 Forecast Sales of Consumer Health by Category: Value 2013-2018
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2013-2018
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements' Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Summary 3 OTC Healthcare Switches 2012-2013
Sources
Summary 4 Research Sources












View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Aflibercept  - Comprehensive patent search

Aflibercept - Comprehensive patent search

  • $ 10 118
  • Industry report
  • March 2015
  • by Ark Patent Intelligence

Imagine having your own team of pharmaceutical patent experts at the click of a button. Used by the world’s leading pharmaceutical companies and legal teams for over 10 years, Ark In-depth Searches are ...

Exenatide  - Comprehensive patent search

Exenatide - Comprehensive patent search

  • $ 10 118
  • Industry report
  • March 2015
  • by Ark Patent Intelligence

Imagine having your own team of pharmaceutical patent experts at the click of a button. Used by the world’s leading pharmaceutical companies and legal teams for over 10 years, Ark In-depth Searches are ...

OpportunityAnalyzer: Acromegaly and Gigantism - Opportunity Analysis and Forecast to 2018

OpportunityAnalyzer: Acromegaly and Gigantism - Opportunity Analysis and Forecast to 2018

  • $ 7 995
  • Industry report
  • December 2014
  • by Global Data

OpportunityAnalyzer: Acromegaly and Gigantism - Opportunity Analysis and Forecast to 2018 Summary GlobalData estimates the 2013 sales for acromegaly and gigantism at approximately $588m across the 6MM ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.